4-9782081-T-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000798.5(DRD5):c.52T>G(p.Tyr18Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000177 in 1,521,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000798.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypouricemia, renal, 2Inheritance: AD, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary renal hypouricemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD5 | ENST00000304374.4 | c.52T>G | p.Tyr18Asp | missense_variant | Exon 1 of 1 | 6 | NM_000798.5 | ENSP00000306129.2 | ||
SLC2A9 | ENST00000503803.5 | n.386-2016A>C | intron_variant | Intron 3 of 3 | 3 | |||||
SLC2A9 | ENST00000508585.5 | n.182-10712A>C | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152224Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000129 AC: 2AN: 155630 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000876 AC: 12AN: 1369138Hom.: 0 Cov.: 30 AF XY: 0.00000298 AC XY: 2AN XY: 671928 show subpopulations
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152342Hom.: 0 Cov.: 34 AF XY: 0.0000805 AC XY: 6AN XY: 74492 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.52T>G (p.Y18D) alteration is located in exon 1 (coding exon 1) of the DRD5 gene. This alteration results from a T to G substitution at nucleotide position 52, causing the tyrosine (Y) at amino acid position 18 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at